JPRN-UMIN000050191
Completed
未知
Characteristics of Dialysis Patients who Developed Non-Occlusive Mesenteric Ischemia - Characteristics of Dialysis Patients who Developed Non-Occlusive Mesenteric Ischemia
Tokyo Bay Urayasu Ichikawa Medical Center0 sites19 target enrollmentFebruary 1, 2023
Conditionson-Occlusive Mesenteric Ischemia
Overview
- Phase
- 未知
- Intervention
- Not specified
- Conditions
- on-Occlusive Mesenteric Ischemia
- Sponsor
- Tokyo Bay Urayasu Ichikawa Medical Center
- Enrollment
- 19
- Status
- Completed
- Last Updated
- 2 years ago
Overview
Brief Summary
No summary available.
Investigators
Eligibility Criteria
Inclusion Criteria
- Not provided
Exclusion Criteria
- Not provided
Outcomes
Primary Outcomes
Not specified
Similar Trials
Not yet recruiting
Not Applicable
Does Evening Primrose Oil Improve Pruritis (Itching) in a Dialysis Population?Pruritis in End Stage Renal FailureFree Fatty Acid Intake and levels in End Stage Renal FailureRenal and Urogenital - Kidney diseaseMetabolic and Endocrine - Other metabolic disordersACTRN12614000677606Department of Renal Medicine, WOLLONGONG hOSPITA90
Not yet recruiting
Not Applicable
Challenges faced by hemodialysis patients in times of COVID- 19 PandemicHealth Condition 1: B972- Coronavirus as the cause of diseases classified elsewhereHealth Condition 2: N186- End stage renal diseaseCTRI/2021/05/033712Kasturba Medical College Manipal
Active, not recruiting
Not Applicable
A Study in Renal Predialysis and Dialysis Patients of the Safety, Tolerability, and Immunogenicity of Recombinant Hepatitis B Vaccine Manufactured With a Modified Process - NDProphylactic vaccination against infection with hepatitis B virus in renal predialysis and dialysis patientsMedDRA version: 9.1Level: LLTClassification code 10038474Term: Renal insufficiencyEUCTR2006-003650-20-ITMerck and Co Inc.276
Active, not recruiting
Phase 1
A Study in Renal Predialysis and Dialysis Patients of the Safety,Tolerability, and Immunogenicity of Recombinant Hepatitis BVaccine Manufactured with a Modified Process - Hepatitis B Vaccine (Recombinant) Dialysis StudyHepatitis BMedDRA version: 8.1Level: LLTClassification code 10019731Term: Hepatitis BEUCTR2006-003650-20-GBMerck & Co Inc.,276
Completed
Not Applicable
Outcomes in Dialysis Patients undergoing Coronary Artery Bypass SurgeryDialysis PatientsJPRN-UMIN000050057ippon Medical School55